Gian Luca Baiocchi1, Domenico D'Ugo2, Daniel Coit3, Richard Hardwick4, Paulo Kassab5, Atsushi Nashimoto6, Daniele Marrelli7, William Allum8, Alfredo Berruti9, Servarayan Murugesan Chandramohan10, Natalie Coburn11, Santiago Gonzàlez-Moreno12, Arnulf Hoelscher13, Edwin Jansen14, Marcis Leja15, Christophe Mariette16, Hans-Joachim Meyer17, Stefan Mönig18, Paolo Morgagni19, Katia Ott20, Shaun Preston21, Sun Young Rha22, Franco Roviello23, Takeshi Sano24, Mitsuru Sasako25, Hideaki Shimada26, Cristoph Schuhmacher27, Jimmy So Bok-Yan28, Vivian Strong29, Takaki Yoshikawa30, Masanori Terashima31, Michail Ter-Ovanesov32, Cornelis Van der Velde33, Maurizio Memo34, Francesco Castelli35,36, Sergio Pecorelli37,38, Claudio Detogni39, Yasuhiro Kodera40, Giovanni de Manzoni41. 1. Surgical Clinic, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. Gianluca.baiocchi@unibs.it. 2. Department of Surgical Sciences, Catholic University, Rome, Italy. ddugo@rm.unicatt.it. 3. Memorial Sloan Kettering Cancer Center, New York, USA. coitd@mskcc.org. 4. Cambridge University Hospitals Foundation Trust, Cambridge, UK. richard.hardwick@addenbrookes.nhs.uk. 5. Santa Casa Medical School, São Paulo, Brazil. paulokassab@terra.com.br. 6. Niigata Cancer Center, Niigata, Japan. nasimoto@niigata-cc.jp. 7. Surgical Oncology, Department of Human Pathology and Oncology, Siena University, Siena, Italy. marrelli@unisi.it. 8. Royal Marsden NHS Foundation Trust, London, UK. william.allum@rmh.nhs.uk. 9. Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy. alfredo.berruti@gmail.com. 10. Department of Surgical Gastroenterology and Center of Excellence for Upper Gastro Intestinal Surgery, Madras Medical College and Rajiv Gandhi Government General Hospital, Chennai, India. smchandra@yahoo.com. 11. Odette Cancer Research, Sunnybrook Research Institute, Toronto, Canada. natalie.coburn@sunnybrook.ca. 12. Anderson Center, Madrid, Spain. gonzalez@mdanderson.es. 13. Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany. arnulf.hoelscher@uk-koeln.de. 14. The Netherlands Cancer Institute, Amsterdam, The Netherlands. epm.jansen@nki.nl. 15. Riga East University Hospital, University of Latvia, Riga, Latvia. cei@latnet.lv. 16. Department of Digestive and Oncological Surgery, University Hospital of Lille, Lille, France. christophe.mariette@chru-lille.fr. 17. Deutsche Gesellschaft für Chirurgie, Luisenstrasse 58/59, 10117, Berlin, Germany. prof.hj.meyer@gmail.com. 18. Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany. stefan.moenig@uk-koeln.de. 19. Department of General Surgery, Morgagni-Pierantoni Hospital, Forlì, Italy. morgagni2002@libero.it. 20. Department of Surgery, University of Heidelberg, Heidelberg, Germany. katja.ott@med.uni-heidelberg.de. 21. The Royal Surrey County Hospital and Minimal Access Therapy Training Unit, Guildford, Surrey, UK. shaun.preston@nhs.net. 22. Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea. rha7655@yuhs.ac. 23. Surgical Oncology, Department of Human Pathology and Oncology, Siena University, Siena, Italy. roviello@unisi.it. 24. Cancer Institute Hospital, Tokyo, Japan. takeshi.sano@jfcr.or.jp. 25. Hyogo College of Medicine, Hyogo, Japan. msasako@hyo-med.ac.jp. 26. Department of Surgery, School of Medicine, Toho University, Tokyo, Japan. hideaki.shimada@med.toho-u.ac.jp. 27. Chirurgische Klinik, Technische Universität München, Munich, Germany. christoph.schuhmacher@tum.de. 28. Department of Surgery, National University Hospital, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. jimmyso@nus.edu.sg. 29. Memorial Sloan Kettering Cancer Center, New York, USA. strongv@mskcc.org. 30. Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan. yoshikawat@kcch.jp. 31. Shizuoka Cancer Center, Shizuoka, Japan. m.terashima@scchr.jp. 32. Blokhin Center for Cancer Research, Russian Academy of Medical Sciences, Moscow, Russia. termd@rambler.ru. 33. Department of Surgical Oncology, Endocrine and Gastrointestinal Surgery, Leiden University Medical Center, Leiden, The Netherlands. c.j.h.van_de_velde@lumc.nl. 34. University of Brescia, Brescia, Italy. maurizio.memo@unibs.it. 35. Medicus Mundi, Brescia, Italy. francesco.castelli@unibs.it. 36. Infectious Diseases, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. francesco.castelli@unibs.it. 37. University of Brescia, Brescia, Italy. sergio.pecorelli@unibs.it. 38. AIFA, Rome, Italy. sergio.pecorelli@unibs.it. 39. Verona University, Verona, Italy. claudio.detogni@gmail.com. 40. Department of Gastroenterological Surgery 2, Nagoya University, Nagoya, Japan. ykodera@med.nagoya-u.ac.jp. 41. 1st Department of General Surgery, Borgo Trento Hospital, University of Verona, Verona, Italy. giovanni.demanzoni@univr.it.
Abstract
PURPOSE: Presently, there is no scientific evidence supporting a definite role for follow-up after gastrectomy for cancer, and clinical practices are quite different around the globe. The aim of this consensus conference was to present an ideal prototype of follow-up after gastrectomy for cancer, based on shared experiences and taking into account the need to rationalize the diagnostic course without losing the possibility of detecting local recurrence at a potentially curable stage. METHODS: On June 19-22, 2013 in Verona (Italy), during the 10th International Gastric Cancer Congress (IGCC) of the International Gastric Cancer Association, a consensus meeting was held, concluding a 6-month, Web-based, consensus conference entitled "Rationale of oncological follow-up after gastrectomy for cancer." RESULTS: Forty-eight experts, with a geographical distribution reflecting different health cultures worldwide, participated in the consensus conference, and 39 attended the consensus meeting. Six statements were finally approved, displayed in a plenary session and signed by the vast majority of the 10th IGCC participants. These statements are attached as an annex to the Charter Scaligero on Gastric Cancer. CONCLUSION: After gastrectomy for cancer, oncological follow-up should be offered to patients; it should be tailored to the stage of the disease, mainly based on cross-sectional imaging, and should be discontinued after 5 years.
PURPOSE: Presently, there is no scientific evidence supporting a definite role for follow-up after gastrectomy for cancer, and clinical practices are quite different around the globe. The aim of this consensus conference was to present an ideal prototype of follow-up after gastrectomy for cancer, based on shared experiences and taking into account the need to rationalize the diagnostic course without losing the possibility of detecting local recurrence at a potentially curable stage. METHODS: On June 19-22, 2013 in Verona (Italy), during the 10th International Gastric Cancer Congress (IGCC) of the International Gastric Cancer Association, a consensus meeting was held, concluding a 6-month, Web-based, consensus conference entitled "Rationale of oncological follow-up after gastrectomy for cancer." RESULTS: Forty-eight experts, with a geographical distribution reflecting different health cultures worldwide, participated in the consensus conference, and 39 attended the consensus meeting. Six statements were finally approved, displayed in a plenary session and signed by the vast majority of the 10th IGCC participants. These statements are attached as an annex to the Charter Scaligero on Gastric Cancer. CONCLUSION: After gastrectomy for cancer, oncological follow-up should be offered to patients; it should be tailored to the stage of the disease, mainly based on cross-sectional imaging, and should be discontinued after 5 years.
Authors: Leila Sisic; Moritz J Strowitzki; Susanne Blank; Henrik Nienhueser; Sara Dorr; Georg Martin Haag; Dirk Jäger; Katja Ott; Markus W Büchler; Alexis Ulrich; Thomas Schmidt Journal: Gastric Cancer Date: 2017-07-24 Impact factor: 7.370
Authors: Giovanni De Manzoni; Daniele Marrelli; Gian Luca Baiocchi; Paolo Morgagni; Luca Saragoni; Maurizio Degiuli; Annibale Donini; Uberto Fumagalli; Maria Antonietta Mazzei; Fabio Pacelli; Anna Tomezzoli; Mattia Berselli; Filippo Catalano; Alberto Di Leo; Massimo Framarini; Simone Giacopuzzi; Luigina Graziosi; Alberto Marchet; Mario Marini; Carlo Milandri; Gianni Mura; Elena Orsenigo; Vittorio Quagliuolo; Stefano Rausei; Riccardo Ricci; Fausto Rosa; Giandomenico Roviello; Andrea Sansonetti; Giovanni Sgroi; Guido Alberto Massimo Tiberio; Giuseppe Verlato; Carla Vindigni; Riccardo Rosati; Franco Roviello Journal: Gastric Cancer Date: 2016-06-02 Impact factor: 7.370